These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35999079)

  • 1. ROS responsive nanoparticles loaded with lipid-specific AIEgen for atherosclerosis-targeted diagnosis and bifunctional therapy.
    Xu H; She P; Ma B; Zhao Z; Li G; Wang Y
    Biomaterials; 2022 Sep; 288():121734. PubMed ID: 35999079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    Small; 2020 Nov; 16(45):e2003253. PubMed ID: 33078569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    ACS Nano; 2020 May; 14(5):5862-5873. PubMed ID: 32379416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.
    Luo X; Zhang M; Dai W; Xiao X; Li X; Zhu Y; Shi X; Li Z
    J Nanobiotechnology; 2024 Jul; 22(1):440. PubMed ID: 39061065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplex Responsive Nanoplatform with Cascade Targeting for Atherosclerosis Photoacoustic Diagnosis and Multichannel Combination Therapy.
    Xu H; She P; Zhao Z; Ma B; Li G; Wang Y
    Adv Mater; 2023 May; 35(21):e2300439. PubMed ID: 36828777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
    Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
    Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis.
    Hou X; Lin H; Zhou X; Cheng Z; Li Y; Liu X; Zhao F; Zhu Y; Zhang P; Chen D
    Carbohydr Polym; 2020 Mar; 232():115787. PubMed ID: 31952595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management.
    Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G
    Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis.
    Li G; Xu F; Yang B; Lu X; Li X; Qi Y; Teng L; Li Y; Sun F; Liu W
    Nanomedicine; 2022 Jul; 43():102557. PubMed ID: 35390526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil membrane biomimetic delivery system (Ptdser-NM-Lipo/Fer-1) designed for targeting atherosclerosis therapy.
    Li W; Liu C; Wang S; Liu N
    IET Nanobiotechnol; 2023 Jun; 17(4):387-395. PubMed ID: 37183611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
    Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X
    Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear Stress and ROS Dual-Responsive RBC-Hitchhiking Nanoparticles for Atherosclerosis Therapy.
    Shen M; Jiang H; Zhao Y; Wu L; Yang H; Yao Y; Meng H; Yang Q; Liu L; Li Y
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43374-43386. PubMed ID: 37669139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis.
    Fang F; Ni Y; Yu H; Yin H; Yang F; Li C; Sun D; Pei T; Ma J; Deng L; Zhang H; Wang G; Li S; Shen Y; Liu X
    Theranostics; 2022; 12(9):4200-4220. PubMed ID: 35673565
    [No Abstract]   [Full Text] [Related]  

  • 18. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of Branched Poly(ß-aminoester) nanoparticles for Interleukin-10 gene delivery in a mouse model of atherosclerosis.
    Distasio N; Dierick F; Ebrahimian T; Tabrizian M; Lehoux S
    Acta Biomater; 2022 Apr; 143():356-371. PubMed ID: 35257950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
    Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.